Suppr超能文献

相似文献

引用本文的文献

1
Wearable Devices for Exercise Prescription and Physical Activity Monitoring in Patients with Various Cardiovascular Conditions.
CJC Open. 2025 Mar 3;7(5):695-706. doi: 10.1016/j.cjco.2025.02.017. eCollection 2025 May.
2
STEPWISE CARDIAC REHABILITATION ADJUSTMENT AFTER EXERCISE-INDUCED IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCK: A CASE REPORT.
J Rehabil Med Clin Commun. 2025 Apr 16;8:42483. doi: 10.2340/jrm-cc.v8.42483. eCollection 2025.
3
Summary of the best evidence for risk stratification of exercise rehabilitation in patients with a cardiac implantable electronic device.
Front Cardiovasc Med. 2024 Nov 25;11:1455486. doi: 10.3389/fcvm.2024.1455486. eCollection 2024.
4
Identifying Elements for a Cardiac Rehabilitation Program for Caregivers: An International Delphi Consensus.
Healthcare (Basel). 2024 Oct 16;12(20):2049. doi: 10.3390/healthcare12202049.
5
Cardiac Rehabilitation to Inpatient Heart Transplant-HRN4HTx Intervention Protocol.
Nurs Rep. 2024 Aug 23;14(3):2084-2094. doi: 10.3390/nursrep14030155.
6
Psychological factors associated with exercise self-efficacy in the recipients of an implantable cardioverter defibrillator.
PLoS One. 2024 Jun 25;19(6):e0305606. doi: 10.1371/journal.pone.0305606. eCollection 2024.
7
Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States.
J Am Heart Assoc. 2023 Aug;12(15):e029126. doi: 10.1161/JAHA.122.029126. Epub 2023 Jul 31.
8
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment.
Int J Heart Fail. 2023 Apr 10;5(2):66-81. doi: 10.36628/ijhf.2023.0011. eCollection 2023 Apr.
9
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment.
Korean Circ J. 2023 Apr;53(4):217-238. doi: 10.4070/kcj.2023.0047.

本文引用的文献

3
Exercise stress test methodology and safety in hypertrophic cardiomyopathy.
Eur J Prev Cardiol. 2020 Nov;27(17):1819-1820. doi: 10.1177/2047487319901059. Epub 2020 Feb 3.
4
Exercise and myocardial injury in hypertrophic cardiomyopathy.
Heart. 2020 Aug;106(15):1169-1175. doi: 10.1136/heartjnl-2019-315818. Epub 2020 Jan 30.
5
Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy.
Eur J Prev Cardiol. 2020 Nov;27(17):1849-1857. doi: 10.1177/2047487319889714. Epub 2019 Dec 1.
6
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
7
Swimming pool saline chlorination units and implantable cardiac devices: A source for potentially fatal electromagnetic interference.
HeartRhythm Case Rep. 2019 Jan 30;5(5):260-261. doi: 10.1016/j.hrcr.2019.01.011. eCollection 2019 May.
8
High-intensity interval training in cardiac resynchronization therapy: a randomized control trial.
Eur J Appl Physiol. 2019 Aug;119(8):1757-1767. doi: 10.1007/s00421-019-04165-y. Epub 2019 May 23.
9
[Cardiac implantable electronic devices : Electromagnetic interference from electrocauterization, lithotripsy and physiotherapy].
Herzschrittmacherther Elektrophysiol. 2019 Jun;30(2):168-176. doi: 10.1007/s00399-019-0620-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验